BRD4 and cancer: JQ1 is one of the first compounds capable of inhibiting, with nanomolar potency, the binding of BRD4 with DNA, consequently preventing the development of cancer cells (to which it activated the process of apoptosis, being, currently, a therapeutic weapon in acute leukemia [80]).